|
1
|
Suvretta Capital Management
New York
|
$179M
|
+$336K
|
+23,840
|
+0.2%
|
|
|
2
|
Jennison Associates
New York
|
$178M
|
-$13.8M
|
-978,917
|
-8%
|
|
|
3
|
Rubric Capital Management (New York)
New York
|
$172M
|
–
|
–
|
–
|
|
|
4
|
|
$139M
|
-$3.61M
|
-256,221
|
-3%
|
|
|
5
|
Frazier Life Sciences Management
Palo Alto,
California
|
$137M
|
–
|
–
|
–
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$107M
|
+$5.32M
|
+377,363
|
+6%
|
|
|
7
|
Polar Capital Holdings
London,
United Kingdom
|
$105M
|
-$9.45M
|
-670,906
|
-9%
|
|
|
8
|
State Street
Boston,
Massachusetts
|
$70M
|
-$6.71M
|
-476,522
|
-10%
|
|
|
9
|
Gilder Gagnon Howe & Co
New York
|
$64.1M
|
+$2.72M
|
+193,060
|
+5%
|
|
|
10
|
|
$60M
|
-$5.71M
|
-405,370
|
-10%
|
|
|
11
|
UBS Group
Zurich,
Switzerland
|
$45.7M
|
+$1.84M
|
+130,478
|
+5%
|
|
|
12
|
Franklin Resources
San Mateo,
California
|
$43.2M
|
-$7.71M
|
-547,552
|
-17%
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$39.8M
|
+$1.05M
|
+74,217
|
+3%
|
|
|
14
|
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
$33.2M
|
–
|
–
|
–
|
|
|
15
|
|
$31.1M
|
-$7.38M
|
-524,069
|
-21%
|
|
|
16
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$31.1M
|
-$5.43M
|
-385,751
|
-16%
|
|
|
17
|
American Century Companies
Kansas City,
Missouri
|
$25.8M
|
+$300K
|
+21,266
|
+1%
|
|
|
18
|
GW&K Investment Management
Boston,
Massachusetts
|
$23.7M
|
-$449K
|
-31,873
|
-2%
|
|
|
19
|
Paradigm Biocapital Advisors
New York
|
$22.9M
|
+$20.6M
|
+1,465,334
|
New
|
|
|
20
|
Cormorant Asset Management
Boston,
Massachusetts
|
$21.1M
|
-$6.69M
|
-475,000
|
-26%
|
|
|
21
|
|
$20.8M
|
+$2.85M
|
+202,286
|
+18%
|
|
|
22
|
|
$17.3M
|
-$2.86M
|
-202,754
|
-16%
|
|
|
23
|
Driehaus Capital Management
Chicago,
Illinois
|
$17.1M
|
-$56.8K
|
-4,034
|
-0.4%
|
|
|
24
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$16.2M
|
-$92.5K
|
-6,568
|
-0.6%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$15.3M
|
-$211K
|
-14,986
|
-2%
|
|
